Skip to main content

Advertisement

Table 3 Adverse events reported in the included RCTs

From: Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

Adverse Events Studies Reporting (n) ACEI/ARB Group (n/n) Control Group (n/n) RR (95% CI) P Value
Hyperkalemia 5 33/604 24/605 1.29 (0.76,2.17) 0.34
Hypotension 5 54/604 54/605 1.03 (0.73,1.45) 0.87
Cough 2 3/75 0/77 2.63 (0.00,39,507.62) 0.84